IDO1 and cancer: Several previous studies have reported that the administration of IDO1 inhibitors improves cancer treatment (Cheong and Sun, 2018; Jung et al., 2019; Lou et al., 2019; Liang et al., 2021; Mo et al., 2021; Odunsi et al., 2022; Zhang et al., 2022).